PACIRA BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $18.9M | $9.0M | $24.9M | $10.9M | $25.8M | $-19.5M | $-10.1M | $-693.0K |
| Depreciation & Amortization | $18.9M | $18.4M | $18.5M | $18.4M | $19.1M | $19.6M | $30.4M | $20.2M |
| Depreciation | $4.5M | $4.1M | $4.2M | $4.1M | $4.7M | $5.3M | $16.2M | $5.8M |
| Amortization | $14.3M | $14.3M | $14.3M | $14.3M | $14.3M | $14.3M | $14.3M | $14.3M |
| Stock-Based Compensation | $12.5M | $13.2M | $12.4M | $12.5M | $11.0M | $12.0M | $12.7M | $12.7M |
| Net Cash from Operating Activities | $53.2M | $49.1M | $47.6M | $44.4M | $43.5M | $19.1M | $42.0M | $42.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.6M | $2.8M | $1.8M | $3.4M | $3.4M | $6.6M | $5.5M | $5.2M |
| Business Acquisitions | $0 | $0 | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-15.2M | $-15.5M | $8.4M | $-4.3M | $7.3M | $66.2M | $11.2M | $-47.5M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $25.0M | $-2.8M | $-1.8M | $-27.8M | $440.0K | $-153.9M | $-58.5M | $-7.8M |
| Net Change in Cash | $63.0M | $30.8M | $54.2M | $12.3M | $51.3M | $-68.6M | $-5.3M | $-12.6M |
| Free Cash Flow | $51.6M | $46.3M | $45.8M | $41.0M | $40.1M | $12.6M | $36.5M | $37.5M |